An investigation by the Associated Press and the Center for Public Integrity sheds light on the political machinations that helped pave the way for America's opioid addiction crisis.

Pharmaceutical interests spent $880 million on lobbying state and federal lawmakers and regulators over the past decade, the investigation found. In contrast, groups that were pushing for greater restrictions on opioids collectively spent only $4 million.

Like all major business interests, pharma also spent big on political campaigns, delivering contributions to 7,100 candidates for state office during the timeframe examined.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.